L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: A randomized, controlled study

Circulation

Volumn 93, Issue 1, 1996, Pages 85-90

  Bode Böger, Stefanie M ^a   Böger, Rainer H ^a   Alfke, Heiko ^a   Heinzel, Doris ^a   Tsikas, Dimitrios ^a   Creutzig, Andreas ^a   Alexander, Klaus ^a   Frölich, Jürgen C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

L arginine; nitric oxide; peripheral vascular disease; prostaglandins

Indexed keywords

ARGININE; NITRIC OXIDE;

ARTERY DILATATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMORAL ARTERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMB BLOOD FLOW; LIMB ISCHEMIA; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SHEAR STRESS;

EID: 0030027672     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.1.85     Document Type: Article

References (39)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature, 1976;263:663-665.
3. Leaf CD, Wishnok JS, Tannenbaum SR. L-Arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun. 1989;163:1032-1037.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
5. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;78:1-5.
6. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol. 1990;30:535-560.
7. Tolins JP, Palmer RMJ, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol. 1990;258:H655-H662.
8. Böger RH, Bode-Böger SM, Gerecke U, Frölich JC. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate excretion and cGMP in rats: correlation with vascular reactivity. Cardiovasc Res. 1994;28: 494-499.
9. 2 as internal standard. Biol Mass Spectrom. 1992;21:97-102.
10. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki F-M, Alexander K, Frölich JC. L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy volunteers. Clin Sci. 1994;87:303-310.
11. Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res. 1988;62:185-190.
12. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:1546-1550.
13. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
14. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 1990;67:1301-1308.
15. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
16. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC. Supplementation of hypercholesterolaemic rabbits with 1-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995;117:273-284.
17. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
18. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol. 1994;23:844-850.
19. 2 production: correlation with changes in human aortic atherosclerotic disease. Arteriosclerosis. 1984;4:70-78.
20. Knapp HR, Healy C, Lawson J, FitzGerald GA. Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. Thromb Res. 1988;50:377-386.
21. 1 in patients with peripheral arterial occlusive disease. Eur J Clin Invest. 1986;16:480-485.
22. 1 therapy of severe claudication. VASA. 1987; 17(suppl):44-46.
23. Gill RA. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol. 1985;11:625-641.
24. Bode-Böger SM, Böger RH, Schröder EP, Frölich JC. Exercise increases systemic NO production in men. J Cardiovasc Risk. 1994; 1:173-178.
25. 15N-labelled analogs. J Chromatogr B. 1994,661: 185-191.
26. Bacchus RA, London DR. The measurement of L-arginine in plasma. Clin Chim Acta. 1971;33:479-482.
27. Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz P, Selwyn AP. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 1989;80:458-465.
28. Guerra R Jr, Brotherton AFA, Goodwin PJ, Clark CR, Armstrong ML, Harrison DG. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF. Blood Vessels. 1989;26:300-314.
29. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol. 1992;19: 619-625.
30. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet. 1990;2:696. Letter.
31. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, Nathorst Westfelt U, Petersson A-S, Waagstein F. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res. 1993;73:1121-1127.
32. 1 in severe peripheral vascular disease. Lancet. 1976;1:810. Letter.
33. 1 on patients with arterial occlusive disease of the leg. Angiology. 1985;36:407-413.
34. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986;8:37-44.
35. Creager MA, Cooke JP, Mendelsohn MD, Gallagher SG, Coleman SM, Loscalzo J Dzau DJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
36. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet. 1991;1:683-684. Letter.
37. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of paniculate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88:10480-10484.
38. Yu X, Li Y, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci. 1994;54:753-758.
39. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992;20(suppl 12):S60-S62.